The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive powerlift ...

The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive ...

Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Medical device and healthcare company Abbott has opened a new facility in Kilkenny, which is expected to employ 800 people.

With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...

Insulin allows cells to absorb and use glucose. In people with insulin resistance, the cells are unable to use insulin effectively. Insulin resistance occurs when cells in the body do not respond ...

Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to offset a hit from ...

The F-22 will receive an embedded set of TacIRST sensors as part of the Infrared Defensive System to enhance aircraft survivability and lethality. Lockheed Martin announced on Jan. 22, 2025 ...

Sensify is a new technology that can turn Zigbee switches, bulbs, and plugs into sensors with a firmware update. This could be how Philips Hue will bring ambient sensing to its smart lights.

Abbott pointed to a number of products contributing to the performance, including the FreeStyle Libre continuous glucose monitor (CGM), Navitor heart valve, TriClip valve repair device, Amplatzer ...

Each participant wore a continuous glucose monitor for 14 days before and at the end of the intervention so the researchers could assess their 24-hour glucose levels. The results show that people on ...